Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

BRD4 inhibitor 20 is an inhibitor of bromodomain-containing protein 2 (BRD2) and BRD4 (IC50s = 24, 18, 19, and 28 nM for BRD2 BD1, BRD2 BD2, BRD4 BD1, and BRD4 BD2, respectively).1 It selectively inhibits the proliferation of HL-60 leukemia and HT-29 colon cancer cells over WI38 fibroblasts (IC50s = 1.35, 4.75, and 44.07 µM, respectively) and induces cell cycle arrest at the G1 phase in HT-29 cells. BRD4 inhibitor 20 decreases the levels of protein arginine methyltransferase 1 (PRMT1), PRMT4, PRMT5, PRMT7, and Myc, reduces histone symmetric and asymmetric dimethylarginine levels, and induces apoptosis in MV4-11 and HL-60 leukemia cells.2 It decreases tumor volume in an MV4-11 mouse xenograft model at 30 mg/kg.
WARNING This product is not for human or veterinary use.
1. Design, synthesis and biological evaluation of indole-
2. A novel 3-